REG - Anheuser-Busch InBev - Publication of Prospectus Supplement <Origin Href="QuoteRef">ABI.BR</Origin>

Anheuser-Busch Inbev SAAnnouncement

11/05/2017 13:20

RNS Number : 8976E
Anheuser-Busch InBev SA/NV
11 May 2017
Publication of Supplement
The following prospectus supplement to the base prospectus dated 6 December 2016 (the "Base Prospectus"), has been approved by the UK Listing Authority and is available for viewing:
Supplement Number 1 dated 11 May 2017 (the "Supplement")
relating to the
Anheuser-Busch InBev SA/NV
40,000,000,000 Euro Medium Term Note Programme
unconditionally and irrevocably guaranteed by
Anheuser-BuschCompanies, LLC, Anheuser-Busch Inbev Finance Inc., Anheuser-Busch Inbev Worldwide Inc., BrandbevS. r.l., BrandbrewS.A. and Cobrew NV
Please read the disclaimer below "Disclaimer - Intended Addressees" before attempting to access this service, as your right to do so is conditional upon complying with the requirements set out below.
To view the Supplement, please paste the following URL into the address bar of your browser:
http://www.rns-pdf.londonstockexchange.com/rns/8976E_3-2017-5-11.pdf
To view the Audited Consolidated Financial Statements, please paste the following URL into the address bar of your browser:
http://www.rns-pdf.londonstockexchange.com/rns/8976E_2-2017-5-11.pdf
To view the First Quarter 2017 Results, please paste the following URL into the address bar of your browser:
http://www.rns-pdf.londonstockexchange.com/rns/8976E_-2017-5-11.pdf
To view the First Quarter Unaudited Interim Report, please paste the following URL into the address bar of your browser:
http://www.rns-pdf.londonstockexchange.com/rns/8976E_1-2017-5-11.pdf
A copy of the Supplement and the documents incorporated by reference therein will be submitted to the National Storage Mechanism and will shortly be available for inspection at: www.morningstar.co.uk/uk/NSM.
For further information, please contact:
Henry Rudd
Email: henry.rudd@ab-inbev.com
Tel: +1 (212) 5 03 18 92
or
Lauren Abbott
Email: lauren.abbott@ab-inbev.com
Tel: +1 (212) 5 73 92 87
or
Gabriel Ventura
Email: gabriel.ventura@ab-inbev.com 
Tel: +1 (212) 4 78 70 31
Anheuser-Busch InBev SA/NV
Brouwerijplein 1, 3000 Leuven, Belgium
This announcement does not constitute or form part of an offer to sell or the solicitation of an offer to subscribe for or otherwise acquire any securities.
DISCLAIMER - INTENDED ADDRESSEES
Please note that the information contained in the Supplement may be addressed to and/or targeted at persons who are residents of particular countries (specified in the Base Prospectus as supplemented by the Supplement) only and is not intended for use and should not be relied upon by any person outside these countries and/or to whom the offer contained in the Base Prospectus as supplemented by the Supplement is not addressed. Prior to relying on the information contained in the Base Prospectus as supplemented by the Supplement you must ascertain from the Base Prospectus as supplemented by the Supplement whether or not you are part of the intended addressees of, and eligible to view, the information contained therein.
In particular, neither this announcement nor the Supplement shall constitute an offer to sell or the solicitation of an offer to buy securities in the United States or in any other jurisdiction in which such offer, solicitation or sale would be unlawful prior to registration, exemption from registration or qualification under the securities law of any such jurisdiction.
The securities described in the Base Prospectus (the "Securities") have not been, and will not be, registered under the U.S. Securities Act of 1933, as amended (the "Securities Act"), or under any relevant securities laws of any state of the United States of America and are subject to U.S. tax law requirements. Subject to certain exceptions, the Securities may not be offered or sold directly or indirectly within the United States or to, or for the account or benefit of, U.S. persons or to persons within the United States of America, as such terms are defined in Regulation S under the Securities Act. Any forwarding, distribution or reproduction of the Base Prospectus in whole or in part is prohibited. Failure to comply with this notice may result in a violation of the Securities Act or the applicable laws of other jurisdictions. There will be no public offering of the Securities in the United States.
Your right to access this service is conditional upon complying with the above requirement.

This information is provided by RNS
The company news service from the London Stock Exchange
  END
PSPBDGDUBGBBGRB